The PBAC proposed expanding the listing of nivolumab and ipilimumab on the PBS.
The PBAC proposed expanding the listing of nivolumab and ipilimumab on the PBS.
The PBAC proposed expanding the listing of nivolumab and ipilimumab on the PBS.